FDA Adverse Event Injury Summary report: N

ACRYSOF RESTOR

MDR report key: 2930351 · Received January 22, 2013

Report

Report Number
1119421-2013-00061
Event Type
Injury
Date Received
January 22, 2013
Date of Event
January 1, 2012
Report Date
December 24, 2012
Manufacturer
ALCON MANUFACTURING, LTD./ HUNTINGTON
Product Code
HQL
PMA / PMN Number
P040020
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. THE PRODUCT HISTORY RECORDS COULD NOT BE REVIEWED BECAUSE THE REPORTING FACILITY DID NOT PROVIDE A LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MANUFACTURING DOCUMENTATION. THE PRODUCT INVESTIGATION COULD NOT IDENTIFY A ROOT CAUSE. NOT ENOUGH INFORMATION WAS PROVIDED TO PROPERLY COMPLETE AN INVESTIGATION. PENGC, ZHAO J, MA L, QU B, SUN Q, ZHANG J. OPTICAL PERFORMANCE AFTER BILATERAL IMPLANTATION OF APODIZED ASPHERIC DIFFRACTIVE MULTIFOCAL INTRAOCULAR LENSES WITH +3.00-D ADDITION POWER. ACTA OPHTHALMOLOGICA SCANDINAVICA FOUNDATION; 2012; 90: E586-E593. (B)(4).

Description of Event or Problem · 1

A JOURNAL ARTICLE REPORTED THE RESULTS OF A STUDY THAT COMPARED THE VISUAL AND OPTICAL PERFORMANCE OF MULTIFOCAL INTRAOCULAR LENSES (IOLS) WITH THE STANDARD ASPHERIC MONOFOCAL IOLS. WHEN IMPLANTED BILATERALLY, THE ARTICLE STATES THAT THE FOLLOWING VISUAL DISTURBANCES WERE REPORTED BY PATIENTS IN BOTH GROUPS: GLARE/FLARE, PROBLEMS WITH NIGHT VISION, HALOS DISTORTED NEAR VISION, DISTORTED FAR VISION, BLURRED NEAR VISION, BLURRED FAR VISION, PROBLEMS WITH COLOR VISION, AND DOUBLE VISION WITH BOTH EYES. ADDITIONAL INFORMATION WAS REQUESTED; HOWEVER, THE SURGEON WAS UNABLE TO PROVIDE FURTHER DETAILS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS FOR THE PATIENTS IN THE MULTIFOCAL IOL GROUP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
30092 ACRYSOF RESTOR INTRAOCULAR LENS HQL ALCON MANUFACTURING, LTD./ HUNTINGTON SN6AD1 UNK

Patients

Seq Age Sex Outcome Treatment
1 Other